secwatch.observer — SEC 8-K summary
======================================

Issuer:     METLIFE INC (MET)
CIK:        0001099219
Form:       8-K
Filed at:   2026-11-10T00:16:08+00:00
Accession:  0001193125-26-454038
Event type: debt
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

MetLife amends $4.0B revolver, extendable to $5.5B, maturing November 2031
--------------------------------------------------------------------------

- Amended and restated credit agreement dated November 9, 2026 provides $4,000,000,000 of borrowings and letters of credit, upsizable to $5,500,000,000 absent an event of default.
- Borrowings must be repaid by November 7, 2031; letters of credit outstanding that day may remain until November 7, 2032. Proceeds for general corporate purposes.
- Pricing set at Level 3 (A-/A3) at closing: 8.0bp commitment fee, Term SOFR +100bp, 87.5bp L/C fee; grid falls to 6.0bp/75bp/62.5bp at A+/A1 or better.
- Bank of America is administrative agent; Wells Fargo and JPMorgan Chase are co-syndication agents; BofA Securities, Wells Fargo Securities and JPMorgan are joint lead arrangers.
- Borrowers are MetLife, Inc. and wholly-owned subsidiary MetLife Funding, Inc., replacing the prior facility dated May 8, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099219/000119312526454038/0001193125-26-454038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099219/000119312526454038/d155870d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-454038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer